UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Breast cancer genomics and immuno-oncological markers to guide immune therapies

Seminars in cancer biology, 2018-10, Vol.52 (Pt 2), p.178-188

2018

Volltextzugriff (PDF)

Tumor-Specific Mitochondrial DNA Variants Are Rarely Detected in Cell-Free DNA

Neoplasia (New York, N.Y.), 2018-07, Vol.20 (7), p.687-696

2018

Volltextzugriff (PDF)

High protein expression of EZH2 is related to unfavorable outcome to tamoxifen in metastatic breast cancer

Annals of oncology, 2014-11, Vol.25 (11), p.2185-2190

2014

Volltextzugriff (PDF)

OC-0443: Radiotherapy sensitivity in breast cancer is influenced by the DNA cytosine deaminase APOBEC3B

Radiotherapy and oncology, 2016-04, Vol.119, p.S206-S207

2016

Volltextzugriff (PDF)

Gene expression profiles in circulating tumor cells to predict prognosis in metastatic breast cancer patients

Annals of oncology, 2015-03, Vol.26 (3), p.510-516

2015

Volltextzugriff (PDF)

Methylated genes as new cancer biomarkers

European journal of cancer (1990), 2009-02, Vol.45 (3), p.335-346

2009

Volltextzugriff (PDF)

PO-0997: Interferon response genes in breast cancer resistance to endocrine treatment and radiotherapy

Radiotherapy and oncology, 2016-04, Vol.119, p.S484-S484

2016

Volltextzugriff (PDF)

mRNA expression profiles of colorectal liver metastases as a novel biomarker for early recurrence after partial hepatectomy

Molecular oncology, 2016-12, Vol.10 (10), p.1542-1550

2016

Volltextzugriff (PDF)

1883 Prevalence and prognostic impact of HER2-positive circulating tumor cells in metastatic breast cancer patients with HER2-negative primary tumors

European journal of cancer (1990), 2015-09, Vol.51, p.S294-S294

2015

Volltextzugriff (PDF)

441 Quality Assurance of Biomarker Assays in Clinical Trials

European journal of cancer (1990), 2012-11, Vol.48, p.137-137

2012

Volltextzugriff (PDF)

5082 POSTER Identification of Protein Markers Predicting Chemotherapy Resistance in Breast Cancer

European journal of cancer (1990), 2011, Vol.47, p.S354-S355

2011

Volltextzugriff (PDF)

1227 POSTER Molecular Portrait of Breast Cancer Cell Lines and Response to Artemisinin

European journal of cancer (1990), 2011, Vol.47, p.S152-S152

2011

Volltextzugriff (PDF)

A1058 - A composite biomarker approach to spare neoadjuvant chemotherapy in select muscle-invasive bladder cancer patients

European urology, 2023-02, Vol.83, p.S1529-S1529

2023

Volltextzugriff (PDF)

A composite biomarker approach to spare neoadjuvant chemotherapy in select muscle-invasive bladder cancer patients

European urology, 2023-02, Vol.83, p.S1529

2023

Volltextzugriff (PDF)

Cost-effectiveness of abemaciclib in early breast cancer patients: one size fits all or tailoring to patients’ needs

European journal of cancer (1990), 2022-11, Vol.175, p.S60-S61

2022

Volltextzugriff (PDF)

29P Plasma ESR1 mutations and outcome to first-line chemotherapy with bevacizumab and paclitaxel in patients with advanced ER-positive/HER2-negative breast cancer

Annals of oncology, 2021-05, Vol.32, p.S32-S33

2021

Volltextzugriff (PDF)

Harmonisation of multi-centre real-time reverse-transcribed PCR results of a candidate prognostic marker in breast cancer: An EU-FP6 supported study of members of the EORTC – PathoBiology Group

European journal of cancer (1990), 2009-01, Vol.45 (1), p.74-81

2009

Volltextzugriff (PDF)

A kinase inhibitor screen reveals MEK1/2 as a novel therapeutic target to antagonize IGF1R-mediated antiestrogen resistance in ERα-positive luminal breast cancer

Biochemical pharmacology, 2022-10, Vol.204, p.115233-115233, Article 115233

2022

Volltextzugriff (PDF)

472P Whole genome sequencing of metastatic CRC reveals footprints from the past and present with future clinical relevance

Annals of oncology, 2020-09, Vol.31, p.S442-S442

2020

Volltextzugriff (PDF)

Characteristics of circulating tumor DNA (ctDNA) in patients with ER-positive (ER+), HER2-negative (HER2-) metastatic breast cancer (MBC) on different lines of endocrine treatment

Annals of oncology, 2019-05, Vol.30, p.iii7-iii7

2019

Volltextzugriff (PDF)

Tumor-Specific Mitochondrial DNA Variants Are Rarely Detected in Cell-Free DNA12

Neoplasia (New York, N.Y.), 2018-05, Vol.20 (7), p.687-696

2018

Volltextzugriff (PDF)

Improved metastasis‐free survival in nonadjuvantly treated postmenopausal breast cancer patients with chemokine receptor 5 del32 frameshift mutations

International journal of cancer, 2015-01, Vol.136 (1), p.91-97

2015

Volltextzugriff (PDF)

The prevalence of CD146 expression in breast cancer subtypes and its relation to outcome

Annals of oncology, 2017-09, Vol.28, p.v61-v61

2017

Volltextzugriff (PDF)

Sensitive detection of mitochondrial DNA variants for analysis of mitochondrial DNA-enriched extracts from frozen tumor tissue

Scientific reports, 2018-02, Vol.8 (1), p.2261-12, Article 2261

2018

Volltextzugriff (PDF)

Passage of Autographa californica Nuclear Polyhedrosis Virus through the Midgut Epithelium of Spodoptera exigua Larvae

Virology (New York, N.Y.), 1995-04, Vol.208 (1), p.328-335

1995

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(43)

Sprache

Englisch
(42)

Erscheinungsjahr

n.n

Thema

Science & Technology
(21)
Life Sciences & Biomedicine
(19)
Humans
(11)
Hematology, Oncology And Palliative Medicine
(10)
Female
(9)
Oncology
(9)
Biological And Medical Sciences
(7)
Breast Cancer
(7)
Laboratorium Voor Virologie
(7)
Laboratory Of Virology
(7)
Animals
(6)
Breast Neoplasms - Genetics
(6)
Prognosis
(6)
Autographa Californica
(5)
Genes
(5)
Molecular Sequence Data
(5)
Pe&rc
(5)
Tumors
(5)
Virology
(5)
Aged
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Breast cancer genomics and immuno-oncological markers to guide immune therapies

Tumor-Specific Mitochondrial DNA Variants Are Rarely Detected in Cell-Free DNA

High protein expression of EZH2 is related to unfavorable outcome to tamoxifen in metastatic breast cancer

OC-0443: Radiotherapy sensitivity in breast cancer is influenced by the DNA cytosine deaminase APOBEC3B

Gene expression profiles in circulating tumor cells to predict prognosis in metastatic breast cancer patients

Methylated genes as new cancer biomarkers

PO-0997: Interferon response genes in breast cancer resistance to endocrine treatment and radiotherapy

mRNA expression profiles of colorectal liver metastases as a novel biomarker for early recurrence after partial hepatectomy

1883 Prevalence and prognostic impact of HER2-positive circulating tumor cells in metastatic breast cancer patients with HER2-negative primary tumors

441 Quality Assurance of Biomarker Assays in Clinical Trials

5082 POSTER Identification of Protein Markers Predicting Chemotherapy Resistance in Breast Cancer

1227 POSTER Molecular Portrait of Breast Cancer Cell Lines and Response to Artemisinin

A1058 - A composite biomarker approach to spare neoadjuvant chemotherapy in select muscle-invasive bladder cancer patients

A composite biomarker approach to spare neoadjuvant chemotherapy in select muscle-invasive bladder cancer patients

Cost-effectiveness of abemaciclib in early breast cancer patients: one size fits all or tailoring to patients’ needs

29P Plasma ESR1 mutations and outcome to first-line chemotherapy with bevacizumab and paclitaxel in patients with advanced ER-positive/HER2-negative breast cancer

Harmonisation of multi-centre real-time reverse-transcribed PCR results of a candidate prognostic marker in breast cancer: An EU-FP6 supported study of members of the EORTC – PathoBiology Group

A kinase inhibitor screen reveals MEK1/2 as a novel therapeutic target to antagonize IGF1R-mediated antiestrogen resistance in ERα-positive luminal breast cancer

472P Whole genome sequencing of metastatic CRC reveals footprints from the past and present with future clinical relevance

Characteristics of circulating tumor DNA (ctDNA) in patients with ER-positive (ER+), HER2-negative (HER2-) metastatic breast cancer (MBC) on different lines of endocrine treatment

Tumor-Specific Mitochondrial DNA Variants Are Rarely Detected in Cell-Free DNA12

Improved metastasis‐free survival in nonadjuvantly treated postmenopausal breast cancer patients with chemokine receptor 5 del32 frameshift mutations

The prevalence of CD146 expression in breast cancer subtypes and its relation to outcome

Sensitive detection of mitochondrial DNA variants for analysis of mitochondrial DNA-enriched extracts from frozen tumor tissue

Passage of Autographa californica Nuclear Polyhedrosis Virus through the Midgut Epithelium of Spodoptera exigua Larvae

Suchergebnisse filtern